TMCI TREACE MEDICAL CONCEPTS, INC.: institutional ownership and insider trading
124 funds reported holding $142M of TREACE MEDICAL CONCEPTS, INC. in their latest 13F filings; in Q2 2026 funds net sold $15.9M, with 31 new positions and 30 funds selling out; over the last 12 months insiders bought $1.24M and sold $0 on the open market.
Famous investors holding TMCI
- Izzy Englander (Millennium Management): $2.94M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $2.32M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $2.11M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $192K, 0.0% of the portfolio
Largest institutional holders of TMCI
- ARMISTICE CAPITAL, LLC — $25.3M
- BANK OF AMERICA CORP /DE/ (BAC, BAC-PB, BAC-PE, BAC-PK, BAC-PL, BAC-PM, BAC-PN, BAC-PO, BAC-PP, BML-PG, BML-PH, BML-PJ, BML-PL) — $13.2M
- GAGNON SECURITIES LLC — $12.1M
- VANGUARD CAPITAL MANAGEMENT LLC — $8.07M
- Gagnon Advisors, LLC — $6.11M
- AQR CAPITAL MANAGEMENT LLC — $5.96M
- VANGUARD GROUP INC — $5.57M
- BlackRock, Inc. (BLK) — $5.49M
- MARSHALL WACE, LLP — $5.29M
- CIBC Bancorp USA Inc. — $4.84M
Recent TMCI insider trades
- Aug 24, 2026: Treace John T. bought 55,944 shares ($247K)
- Jun 11, 2026: Treace John T. bought 24,606 shares ($99.1K)
- Jun 1, 2026: Treace John T. bought 50,000 shares ($178K)
- May 28, 2026: Treace John T. bought 115,520 shares ($340K)
5%+ owners
- John T. Treace: 19.2% (Schedule 13G/A, filed Aug 12, 2026)
- Armistice Capital, LLC: 9.8% (Schedule 13G/A, filed Aug 14, 2026)
- BANK OF AMERICA CORP /DE/: 5.5% (Schedule 13G, filed May 14, 2026)